These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7121730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW, Ropper AH, Zervas NT.
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [Abstract] [Full Text] [Related]

  • 3. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H, Nagasawa S, Yonekawa Y, Naruo Y, Oda Y.
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y, Handa H, Nagasawa S, Naruo Y, Asato R, Yonekawa Y.
    Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
    [Abstract] [Full Text] [Related]

  • 5. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R, Peerless SJ, Hunter IG.
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [Abstract] [Full Text] [Related]

  • 6. [Effect of perfluorochemicals on experimental cerebral ischemia].
    Yamashita K, Yamaguchi S, Kobayashi S.
    No To Shinkei; 1989 Dec; 41(12):1205-10. PubMed ID: 2627538
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage.
    Karn KE, Ogburn PL, Julian T, Cerra FB, Hammerschmidt DE, Vercellotti G.
    Obstet Gynecol; 1985 Jan; 65(1):127-30. PubMed ID: 3871250
    [Abstract] [Full Text] [Related]

  • 14. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T, Yokoyama K, Naito R.
    Prog Clin Biol Res; 1981 Jan; 55():609-28. PubMed ID: 7027272
    [Abstract] [Full Text] [Related]

  • 15. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK, Cobb MA, Virmani R, Gay JC, Light RT, Forman MB.
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [Abstract] [Full Text] [Related]

  • 16. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S, Handa H, Naruo Y, Oda Y, Yonekawa Y, Takebe Y.
    Neurol Res; 1981 Mar; 3(3):237-50. PubMed ID: 6122175
    [Abstract] [Full Text] [Related]

  • 17. [The effect of low dose dopamine on CBF in patients with subarachnoid hemorrhage].
    Ihara I, Kikuchi H.
    No To Shinkei; 1986 Jul; 38(7):647-54. PubMed ID: 3756031
    [Abstract] [Full Text] [Related]

  • 18. Modification of cerebral ischemia with Fluosol.
    Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG.
    Stroke; 1985 Jul; 16(1):38-43. PubMed ID: 3966263
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ, Ishikawa R, Hunter IG, Peerless MJ.
    Stroke; 1981 Jul; 12(5):558-63. PubMed ID: 6795765
    [Abstract] [Full Text] [Related]

  • 20. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T, Ohyanagi H.
    Int Anesthesiol Clin; 1985 Jul; 23(1):169-84. PubMed ID: 3980104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.